Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists, endocrinologists and other physicians.

Stock Info

NASDAQ: SNTS
Current Price: 2.24
Change: -0.01

9/3/2010 3:44:07 PM EST
Quotes delayed 20 minutes.

Glumetza
Zegerid


8/30/2010
Santarus Extends Maturity of $25 Million Revolving Line of Credit to July 2013

8/2/2010
Santarus Reports Second Quarter 2010 Financial Results

7/28/2010
Santarus to Present at BMO Capital Markets 10th Annual Focus on Healthcare Conference


Clinician Info
Patient Info

Careers Santarus is hiring skilled people like you. Join our team today!